Avadel Pharmaceuticals (AVDL) Gross Profit (2016 - 2020)
Historic Gross Profit for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to $6.8 million.
- Avadel Pharmaceuticals' Gross Profit fell 5114.84% to $6.8 million in Q2 2020 from the same period last year, while for Mar 2021 it was $6.8 million, marking a year-over-year decrease of 8442.74%. This contributed to the annual value of $16.6 million for FY2020, which is 6476.53% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Gross Profit stood at $6.8 million for Q2 2020, which was down 5114.84% from $9.8 million recorded in Q1 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Gross Profit peaked at $48.6 million during Q1 2017, and registered a low of $6.8 million during Q2 2020.
- Over the past 5 years, Avadel Pharmaceuticals' median Gross Profit value was $26.2 million (recorded in 2018), while the average stood at $24.7 million.
- In the last 5 years, Avadel Pharmaceuticals' Gross Profit skyrocketed by 104198.25% in 2016 and then tumbled by 5344.57% in 2018.
- Avadel Pharmaceuticals' Gross Profit (Quarter) stood at $40.5 million in 2016, then dropped by 24.18% to $30.7 million in 2017, then tumbled by 45.84% to $16.6 million in 2018, then plummeted by 48.39% to $8.6 million in 2019, then dropped by 20.69% to $6.8 million in 2020.
- Its Gross Profit stands at $6.8 million for Q2 2020, versus $9.8 million for Q1 2020 and $8.6 million for Q4 2019.